Laia Ruiz

Top-line Takeaways: New COVID-19 Vaccines Trials in Sub-Saharan Africa (UBUNTU trial)

Last April 6, the COVID Advocates Advisory Board (CAAB), the Coalition to Accelerate and Support Prevention Research (CASPR) and AVAC held a webinar with Dr. Nigel Garrett, from the Centre for the AIDS Programme of Research in South Africa (CAPRISA) and international Co-chair on the COVPN 3008 Ubuntu mRNA vaccine trial. “It is key to

Top-line Takeaways: New COVID-19 Vaccines Trials in Sub-Saharan Africa (UBUNTU trial) Read More »

CAAB Vax meets Johnson & Johnson/Janssen to clarify doubts on its covid-19 vaccine

Last November 15, a group of advocates working on vaccine access issues met with representatives of Johnson & Johnson (J&J)/Janssen to discuss issues related to the company’s mono-dose vaccine, popularly known as the Janssen Adeno26 COVID vaccine. The meeting was an opportunity for advocates to pose questions dealing with the safety issues, dosage, the current

CAAB Vax meets Johnson & Johnson/Janssen to clarify doubts on its covid-19 vaccine Read More »

Register for the upcoming webinar: Understanding — and Improving — COVID-19 Vaccine Uptake

This session will be the first of the series “Building Vaccine Confidence in anticipation of future vaccine”. The webinar series goal is to unpack important topics related to pandemic response, with a particular emphasis on how lessons learned from COVID-19 can impact global health policy and practice moving forward.

Register for the upcoming webinar: Understanding — and Improving — COVID-19 Vaccine Uptake Read More »